Submissions from 2025
A prospective, multicenter analysis of the integrated 31-gene expression profile test for sentinel lymph node biopsy (i31-GEP for SLNB) test demonstrates reduced number of unnecessary SLNBs in patients with cutaneous melanoma., J Michael Guenther, Andrew Ward, Brian J Martin, Mark Cripe, Rohit Sharma, Stanley P Leong, Joseph I Clark, John Hamner, and Timothy Beard
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703., Shernan G Holtan, Javier Bolaños-Meade, Monzr M Al Malki, Juan Wu, Carrie L Kitko, Ran Reshef, Andrew R Rezvani, Brian C Shaffer, Melhem M Solh, Janny M Yao, Lyndsey Runaas, Hany Elmariah, Karilyn T Larkin, Najla El Jurdi, Mahasweta Gooptu, Alison W Loren, Aric C Hall, Amin M Alousi, Omer Jamy, William Clark, Leslie Kean, Ami S Bhatt, Miguel-Angel Perales, Kristy Applegate, Yvonne Adeduni Efebera, Eric Leifer, Richard J Jones, Mary M Horowitz, Deborah Mattila, Wael Saber, Mehdi Hamadani, and Michael J Martens
Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancer., Vishnu Prasath, Hinda Boutrid, Robert Wesolowski, Mahmoud Abdel-Rasoul, Cynthia Timmers, Maryam Lustberg, Rachel M Layman, Erin Macrae, Ewa Mrozek, Charles Shapiro, Kristyn Glover, Mark Vater, G Thomas Budd, Lyndsay Harris, Claudine Isaacs, Claire Dees, Charles M Perou, Gary L Johnson, Andrew Poklepovic, Helen Chen, Miguel Villalona-Calero, William Carson, Daniel G Stover, and Bhuvaneswari Ramaswamy
A plain language summary of the final analysis of the GRIFFIN study of daratumumab plus lenalidomide, bortezomib, and dexamethasone for people with newly diagnosed multiple myeloma., Peter M Voorhees, Douglas W Sborov, Jacob Laubach, Jonathan L Kaufman, Brandi Reeves, Cesar Rodriguez, Rebecca Silbermann, Luciano J Costa, Larry D Anderson, Nitya Nathwani, Nina Shah, Naresh Bumma, Yvonne A Efebera, Sarah A Holstein, Caitlin Costello, Andrzej Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Shira Dinner, Katharine S Gries, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Saad Z Usmani, and Paul G Richardson
Submissions from 2024
Late-onset cardiotoxicity in patients with HER2-positive metastatic breast cancer receiving trastuzumab-based therapy., Shuroug A Alowais, Samantha O Luk, E Bridget Kim, Nada Alsuhebany, and Mark Zangardi
Oncology stewardship practice in the United States: A Hematology/Oncology Pharmacy Association national survey., Marisela Tan Banez, Sol Atienza, Allison Butts, Megan Derba, Katie Dicke, Kimberly Haverstick, Bernadette B Heron, Sarah K Cimino, Matthew Shane Loop, Shannon Hough, Julianna A Merten, Donald C Moore, Vishal Shah, Kate D Taucher, Junyu Matt Zhang, and Zahra Mahmoudjafari
Real-world multiple myeloma risk factors and outcomes by non-Hispanic Black/African American and non- Hispanic White race/ethnicity in the United States., Tondre Buck, Monique A Hartley-Brown, Yvonne A Efebera, Carter P Milner, Jeffrey A Zonder, Paul G Richardson, Taylor Salinardi, and Megan S Rice
Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer - An NRG/GOG study., John K Chan, Chunqiao Tian, Joshua P Kesterson, Ken Y Lin, Kathleen Darcy, Michael T Richardson, Daniel S Kapp, Bradley J Monk, Leah McNally, Lisa Landrum, Larry Copeland, Joan L Walker, Robert M Wenham, Neil Phippen, Nick M Spirtos, Krishnansu Tewari, Mark Shahin, Laurel Berry, and Jeffery G Bell
Liver-Directed Locoregional Therapies for Neuroendocrine Liver Metastases: Recent Advances and Management., Cody R Criss and Mina S Makary
A robust quality infrastructure is key to safe and effective delivery of immune effector cells: how FACT-finding can help., Kevin J Curran, Sarah Nikiforow, Carlos Bachier, Yen-Michael Hsu, David Maloney, Marcela V Maus, Philip McCarthy, David Porter, Patricia Shi, Elizabeth J Shpall, Basem William, Kara Wacker, Phyllis Warkentin, and Helen E Heslop
Impact of chronic graft- versus-host disease on non-relapse mortality and survival, Justin Jiang, Audrey M Sigmund, Qiuhong Zhao, Patrick Elder, Sumithira Vasu, Samantha Jaglowski, Alice Mims, Hannah Choe, Karilyn Larkin, Sarah Wall, Nicole Grieselhuber, Basem William, Sam Penza, Don M Benson, Yvonne A Efebera, and Nidhi Sharma
Adult-Onset T-Cell Acute Lymphoblastic Lymphoma-Leukemia Presenting With Petechial Rash: A Case Report., Kelly Kimball, Vissy Elad, Edward J Hamad, and Christopher Wasco
Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN study., Ajay K Nooka, Jonathan L Kaufman, Cesar Rodriguez, Andrzej Jakubowiak, Yvonne Efebera, Brandi Reeves, Tanya M Wildes, Sarah A Holstein, Larry D Anderson, Ashraf Badros, Leyla Shune, Ajai Chari, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Peter M Voorhees, Saad Z Usmani, and Paul G Richardson
ANCHOR: melflufen plus dexamethasone and daratumumab or bortezomib in relapsed/refractory multiple myeloma: final results of a phase I/IIa study., Enrique M Ocio, Yvonne A Efebera, Roman Hájek, Jan Straub, Vladimir Maisnar, Jean-Richard Eveillard, Lionel Karlin, María-Victoria Mateos, Albert Oriol, Vincent Ribrag, Paul G Richardson, Stefan Norin, Jakob Obermüller, Nicolaas A Bakker, and Luděk Pour
Assessing Radiology and Radiation Therapy Needs for Cancer Care in Low-and-Middle-Income Countries: Insight From a Global Survey of Departmental and Institutional Leaders., Stephanie A Parker, Joseph Weygand, Beata Gontova Bernat, Amanda M Jackson, Osama Mawlawi, Izabella Barreto, Yao Hao, Rao Khan, Afua A Yorke, William Swanson, Mohammed Saiful Huq, Eugene Lief, Cesar Della Biancia, Christopher F Njeh, Ahmad Al-Basheer, Oi Wai Chau, Stephen Avery, Wilfred Ngwa, and Peter A Sandwall
Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival., Marcelo C Pasquini, Paul K Wallace, Brent Logan, Manmeet Kaur, Joseph D Tario, Alan Howard, Yali Zhang, Claudio Brunstein, Yvonne Efebera, Nancy Geller, Sergio Giralt, Parameswaran Hari, Mary M Horowitz, John Koreth, Amrita Krishnan, Heather Landau, George Somlo, Nina Shah, Edward Stadtmauer, Dan T Vogl, David H Vesole, Philip L McCarthy, and Theresa Hahn
Differential expression of WNT5A long and short isoforms in non-muscle-invasive bladder urothelial carcinoma., Amy M Strope, Cody Phillips, Sabin Khadgi, Scott A Jenkinson, Karen T Coschigano, and Ramiro Malgor
The AAPM/ASTRO 2023 Core Physics Curriculum for Radiation Oncology Residents., Matthew T Studenski, Ashley Cetnar, Colleen M Derosiers, Sarah Dooley, Justin D Gagneur, Paulina E Galavis, Kristofer K Kainz, Narottam Lamichhane, Peter A Sandwall, Jiajian Shen, Christopher J Tien, Dongxu Wang, Iris Z Wang, Heather K Warkentin, and Sarah McAvoy
Evaluation of proteinuria monitoring practice patterns and treatment implications in patients with cancer receiving bevacizumab products., Kuan Sturgill, Katie Dicke, Mark Zangardi, and Kara Osborne
Safety and efficacy of peptide receptor radionuclide therapy in neuroendocrine tumors: A single center experience., Vineeth Sukrithan, Heather Armbruster, Sherise Rogers, Sherry Mori Vogt, Cassandra Grenade, Claire Verschraegen, Ye Zhou, Ashima Goyal, Mona Natwa, Akram Hussein, Hallie Barr, Dramane Konate, Rochelle Batdorf, Andrew Brown, Bonnie Williams, Songzhu Zhao, Lai Wei, Menglin Xu, Manisha H Shah, and Bhavana Konda
Alliance A061202: ixazomib, pomalidomide, and dexamethasone for patients with lenalidomide-refractory MM in first relapse., Peter Voorhees, Vera Suman, Yvonne Efebera, Noopur Raje, Sascha Tuchman, Cesar Rodriguez, Jacob Laubach, Misty Bova-Solem, Destin Carlisle, Saad Usmani, Philip McCarthy, and Paul G Richardson
Retrospective evaluation of Penguin Cold Caps for chemotherapy-induced alopecia., Dale Weaver, Michelle L Pershing, Bethany Golden, Laura Hammel, Pauline Kefalas Russ, and Mark Cripe
Submissions from 2023
A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors., Sonia M Abuzakhm, Vineeth Sukrithan, Briant Fruth, Rui Qin, Jonathan Strosberg, Timothy J Hobday, Thomas Semrad, Diane Reidy-Lagunes, Hedy Lee Kindler, George P Kim, Jennifer J Knox, Andreas Kaubisch, Miguel Villalona-Calero, Helen Chen, Charles Erlichman, and Manisha H Shah
Outcomes of the "BRCA Quality Improvement Dissemination Program": An initiative to improve patient receipt of cancer genetics services at five health systems., Erica M Bednar, Minxing Chen, Michael T Walsh, Amanda L Eppolito, Molly H Klein, Kelly Teed, Brittany Hodge, Jordan Hunter, Han Gill Chao, Dillon Davis, Wilshauna Serchion, Cara Yobbi, Rebekah Krukenberg, Sandra B Jenkinson, Jennifer J Moore, Cassandra Garcia, Fatimaeliza Gonzalez, Towanna Murray, Linda D Nielsen, Brenda Ho, Megan Haas, Sarah B Greenzweig, Abby Anderson, Christina Johnson, Nichole A Morman, Elizabeth Bowdish, Emaline Wise, Julia N Cooper, Pauline Kefalas Russ, Katelyn Tondo-Steele, Buonarotti F de Gracia, Brooke Levin, Kristin Mattie, Kathryn Zarnawski, Molly Kalasinski, Jennifer Stone, Caitlin O'Brien, Alexa Bream, Aidan M Kennedy, Rachel A Paul, Michelle Bilbao, Maureen Romero, Rebecca L Carr, Jennifer M Siettmann, Anna K Vercruyssen, Kaycee Leon, Banu K Arun, Andrew V Grainger, David P Warshal, Erin Bowman, Timothy A Goedde, Deepa Halaharvi, Kellie Rath, Generosa Grana, Lida Mina, and Karen H Lu
Implementation and outcome evaluations of a multi-site improvement program in cancer genetics., Erica M Bednar, Blake Harper, Michael T Walsh, Ruth Rechis, Michelle Bilbao, Rebecca L Carr, Amanda L Eppolito, Timothy Goedde, Brooke Levin, Kristin Mattie, Nichole A Morman, Kellie Rath, Pauline Russ, Jennifer M Siettmann, David Warshal, Emaline Wise, Cara Yobbi, and Karen H Lu
Optimized 18F-FDG PET-CT Method to Improve Accuracy of Diagnosis of Metastatic Cancer., Richard Black, Jelle Barentsz, David Howell, David G Bostwick, and Stephen B Strum
Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401., David J Chung, Nina Shah, Juan Wu, Brent Logan, Lina Bisharat, Natalie Callander, Giulia Cheloni, Kenneth Anderson, Thinle Chodon, Binod Dhakal, Steve Devine, Poorvi Somaiya Dutt, Yvonne Efebera, Nancy Geller, Haider Ghiasuddin, Peiman Hematti, Leona Holmberg, Alan Howard, Bryon Johnson, Dimitra Karagkouni, Hillard M Lazarus, Ehsan Malek, Philip McCarthy, David McKenna, Adam Mendizabal, Ajay Nooka, Nikhil Munshi, Lynn O'Donnell, Aaron P Rapoport, Jane Reese, Jacalyn Rosenblatt, Robert Soiffer, Dina Stroopinsky, Lynne Uhl, Ioannis S Vlachos, Edmund K Waller, James W Young, Marcelo C Pasquini, and David Avigan
Recent Advances in Image-Guided Locoregional Therapies for Primary Liver Tumors., Cody R Criss and Mina S Makary
Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents., Muhammad Salman Faisal, Walter Hanel, Timothy Voorhees, Rui Li, Ying Huang, Abdullah Khan, David Bond, Yazeed Sawalha, John Reneau, Lapo Alinari, Robert Baiocchi, Beth Christian, Kami Maddocks, Yvonne Efebera, Sam Penza, Ayman Saad, Jonathan Brammer, Marcos DeLima, Samantha Jaglowski, and Narendranath Epperla
Prediction of Rapid Early Progression and Survival Risk with Pre-Radiation MRI in WHO Grade 4 Glioma Patients., Walia Farzana, Mustafa M Basree, Norou Diawara, Zeina A Shboul, Sagel Dubey, Marie M Lockhart, Mohamed Hamza, Joshua D Palmer, and Khan M Iftekharuddin
A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma., Walter Hanel, Polina Shindiapina, David A Bond, Yazeed Sawalha, Narendranath Epperla, Timothy Voorhees, Rina Li Welkie, Ying Huang, Gregory K Behbehani, Xiaoli Zhang, Eric McLaughlin, Wing K Chan, Jonathan E Brammer, Samantha Jaglowski, John C Reneau, Beth A Christian, Basem M William, Jonathon B Cohen, Robert A Baiocchi, Kami Maddocks, Kristie A Blum, and Lapo Alinari
The clinicopathologic significance of NPM1 mutation and ability to detect mutated NPM1 by immunohistochemistry in non-AML myeloid neoplasms., Hatem Kaseb, Valeria Visconte, Daniel S Socha, Genevieve M Crane, Lisa Durkin, James R Cook, Jaroslaw P Maciejewski, Eric D Hsi, and Heesun J Rogers
Comparison of Patient Outcomes With Two Different Formulations of Melphalan as Conditioning Chemotherapy for Autologous Hematopoietic Cell Transplantation in Multiple Myeloma., Abdullah M Khan, Filiz Yucebay, Qiuhong Zhao, Elvira Umyarova, Francesca Cottini, Naresh Bumma, Ashley Rosko, Don Benson, Nidhi Sharma, Yvonne Efebera, and Srinivas Devarakonda
Age is No Barrier: CAR-T Therapy in Older Adults., Joseph E Maakaron and Basem M William
A multicenter study of clinical impact of variant of uncertain significance reclassification in breast, ovarian and colorectal cancer susceptibility genes., Sukh Makhnoon, Brooke Levin, Megan Ensinger, Kristin Mattie, Robert J Volk, Zhongming Zhao, Tito Mendoza, Sanjay Shete, Laila Samiian, Generosa Grana, Andrew Grainger, Banu Arun, Brian H Shirts, and Susan K Peterson
Methodological Issues in Study of Daily Insulin Dose and Cancer Risk Among Patients With Type 1 Diabetes-Reply., Yuanjie Mao and Wenjun Zhong
Early outcomes of ultra-hypofractionated preoperative radiation therapy for soft tissue sarcoma followed by immediate surgical resection., Zachary S Mayo, Shireen Parsai, Wafa Asha, Mina Dinh, Nathan Mesko, Lukas Nystrom, Chirag S Shah, Jacob G Scott, and Shauna R Campbell
Prevalence of type 2 diabetes diagnoses in the perioperative and survivorship periods following surgical management of endometrial cancer: An opportunity for screening and intervention?, Molly Morton, Eric M McLaughlin, Corinne A Calo, Michelle Lightfoot, Kristin L Bixel, David E Cohn, Casey M Cosgrove, Larry J Copeland, David M O'Malley, Christa I Nagel, and Laura M Chambers
Patient-driven decisions and perceptions of the 'safest possible choice': insights from patient-provider conversations about how some breast cancer patients choose contralateral prophylactic mastectomy., Tasleem J Padamsee, Crystal Phommasathit, Paige Swinehart-Hord, Shibani Chettri, Kaleigh Clevenger, Michael F Rayo, Doreen M Agnese, Jose G Bazan, Natalie Jones, and Clara N Lee
International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship., Issam I Raad, Ray Hachem, Nigo Masayuki, Tarcila Datoguia, Hiba Dagher, Ying Jiang, Vivek Subbiah, Bilal Siddiqui, Arnaud Bayle, Robert Somer, Ana Fernández Cruz, Edward Gorak, Arvinder Bhinder, Nobuyoshi Mori, Nelson Hamerschlak, Samuel Shelanski, Tomislav Dragovich, Yee Elise Vong Kiat, Suha Fakhreddine, Abi Hanna Pierre, Roy F Chemaly, Victor Mulanovich, Javier Adachi, Jovan Borjan, Fareed Khawaja, Bruno Granwehr, Teny John, Eduardo Yepez Yepez, Harrys A Torres, Natraj Reddy Ammakkanavar, Marcel Yibirin, Cielito C Reyes-Gibby, Mala Pande, Noman Ali, Raniv Dawey Rojo, Shahnoor M Ali, Rita E Deeba, Patrick Chaftari, Takahiro Matsuo, Kazuhiro Ishikawa, Ryo Hasegawa, Ramón Aguado-Noya, Alvaro Garcia García, Cristina Traseira Puchol, Dong Gun Lee, Monica Slavin, Benjamin Teh, Cesar A Arias, Dimitrios P Kontoyiannis, Alexandre E Malek, and Anne-Marie Chaftari
Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel., Noopur Raje, Kenneth Anderson, Hermann Einsele, Yvonne Efebera, Francesca Gay, Sarah P Hammond, Alexander M Lesokhin, Sagar Lonial, Heinz Ludwig, Philippe Moreau, Krina Patel, Karthik Ramasamy, and Maria-Victoria Mateos
Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41., Priya Rastogi, Gong Tang, Saima Hassan, Charles E Geyer, Catherine A Azar, Gustav C Magrinat, J Marie Suga, Harry D Bear, Luis Baez-Diaz, Shakir Sarwar, Jean-Francois Boileau, Adam M Brufsky, Henry R Shibata, Hanna Bandos, Soonmyung Paik, Greg Yothers, Sandra M Swain, Eleftherios P Mamounas, and Norman Wolmark
Survival outcomes following autologous stem cell transplant with melphalan 140mg/m, Nidhi Sharma, Evan Benson, Qiuhong Zhao, Jordan Nunnelee, Francesca Cottini, Patrick Elder, Ashley Rosko, Naresh Bumma, Abdullah Khan, Elvira Umyarova, Srinivas Devarakonda, Yvonne A Efebera, and Don M Benson
Editorial: Autologous and Allogeneic Stem Cell Transplant in Cancer Therapy., Nidhi Sharma and Yvonne A Efebera
Neutrophil to lymphocyte ratio (NTLR) predicts local control and overall survival after stereotactic body radiotherapy (SBRT) in metastatic sarcoma., Eashwar Somasundaram, Peter M Anderson, Timothy D Smile, Ahmed Halima, James B Broughman, Chandana A Reddy, Shireen Parsai, Jacob G Scott, Timothy Chan, Shauna Campbell, Lilyana Angelov, Stacey Zahler, Matteo Trucco, Stefanie M Thomas, Shavaughn Johnson, Peng Qi, Anthony Magnelli, and Erin S Murphy
Dosimetric and radiobiological comparison between conventional and hypofractionated breast treatment plans using the Halcyon system., Duong Thanh Tai, Luong Tien Phat, Nguyen Ngoc Anh, Huynh Van Tran Sang, Tran Minh Loc, Nguyen Xuan Hai, Peter A Sandwall, David Bradley, and James C L Chow
Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN): final analysis of an open-label, randomised, phase 2 trial., Peter M Voorhees, Douglas W Sborov, Jacob Laubach, Jonathan L Kaufman, Brandi Reeves, Cesar Rodriguez, Ajai Chari, Rebecca Silbermann, Luciano J Costa, Larry D Anderson, Nitya Nathwani, Nina Shah, Naresh Bumma, Yvonne A Efebera, Sarah A Holstein, Caitlin Costello, Andrzej Jakubowiak, Tanya M Wildes, Robert Z Orlowski, Kenneth H Shain, Andrew J Cowan, Shira Dinner, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Saad Z Usmani, and Paul G Richardson
Timing of sentinel lymph node biopsy in cutaneous squamous cell carcinoma., Trent D Walker, Austin Cusick, Kathryn T Shahwan, and David R Carr
International Collaboration on Palliative Care Development Between ASCO and the Land of Hornbills., Yin Yee Wong, Aaron Zi Jian Chiew, Vanessa Eaton, Frank D Ferris, Megan Kremzier, Boon Leong Lim, Winnie Hui Yee Ling, Asri Said, Vanessa Sarchet, Tung Hui Tiong, Pei Jye Voon, and Yoke Ling Choo
Submissions from 2022
Identification of circulating plasma ceramides as a potential sexually dimorphic biomarker of pancreatic cancer-induced cachexia., Jeffery M Chakedis, Mary E Dillhoff, Carl R Schmidt, Priyani V Rajasekera, David C Evans, Terence M Williams, Denis C Guttridge, and Erin E Talbert
A plain language summary of daratumumab plus lenalidomide/bortezomib/dexamethasone in transplant-eligible Black patients with newly diagnosed multiple myeloma in the GRIFFIN study., Ajay K Nooka, Jonathan L Kaufman, Cesar Rodriguez, Andrzej Jakubowiak, Yvonne Efebera, Brandi Reeves, Tanya Wildes, Sarah A Holstein, Larry D Anderson, Ashraf Badros, Leyla Shune, Ajai Chari, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Paul G Richardson, and Peter Voorhees